No Data
No Data
Psychedelic Drug Developer Lykos Could Get Lifeline From Former Tesla Board Member
Cybin to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025
Express News | Cybin Announces Poster Presentations at the 2024 American College of Neuropsychopharmacology Annual Meeting, Including Cyb003 12-Month Efficacy Results
Cybin Announces Poster Presentations at the 2024 American College of Neuropsychopharmacology Annual Meeting, Including CYB003 12-Month Efficacy Results
Facet Life Sciences Named Regulatory Partner for Cybin's Neuropsychiatry Therapeutics Development Pipeline
Cybin to Discuss Breakthrough Treatments at Fireside Chat